INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM.
Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.
The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
Endoscopic examination, therapy or surgery of the esophagus.
Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
STOMACH herniation located at or near the diaphragmatic opening for the ESOPHAGUS, the esophageal hiatus.
Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
A stricture of the ESOPHAGUS. Most are acquired but can be congenital.
A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.
Endoscopic examination, therapy or surgery of the gastrointestinal tract.
Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS.
Analysis of the HYDROGEN ION CONCENTRATION in the lumen of the ESOPHAGUS. It is used to record the pattern, frequency, and duration of GASTROESOPHAGEAL REFLUX.
Endoscopic examination, therapy or surgery of the digestive tract.
Substernal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus.
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX.
An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa.
Measurement of the pressure or tension of liquids or gases with a manometer.
Disorders affecting the motor function of the UPPER ESOPHAGEAL SPHINCTER; LOWER ESOPHAGEAL SPHINCTER; the ESOPHAGUS body, or a combination of these parts. The failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus (GASTROESOPHAGEAL REFLUX). Other disorders include hypermotility (spastic disorders) and markedly increased amplitude in contraction (nutcracker esophagus).
A species of baboon in the family CERCOPITHECIDAE found in southern equatorial and east Africa. They are smaller than PAPIO ANUBIS and have a thinner mane.
Endoscopic examination, therapy or surgery of the interior of the stomach.
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Back flow of gastric contents to the LARYNGOPHARYNX where it comes in contact with tissues of the upper aerodigestive tract. Laryngopharyngeal reflux is an extraesophageal manifestation of GASTROESOPHAGEAL REFLUX.
The physiologic or functional barrier to GASTROESOPHAGEAL REFLUX at the esophagogastric junction. Sphincteric muscles remain tonically contracted during the resting state and form the high-pressure zone separating the lumen of the ESOPHAGUS from that of the STOMACH. (Haubrich et al, Bockus Gastroenterology, 5th ed., pp399, 415)
Pathological processes in the ESOPHAGUS.
Retrograde flow of duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the STOMACH.
Mobilization of the lower end of the esophagus and plication of the fundus of the stomach around it (fundic wrapping) in the treatment of GASTROESOPHAGEAL REFLUX that may be associated with various disorders, such as hiatal hernia. (From Dorland, 28th ed)
Compounds that contain benzimidazole joined to a 2-methylpyridine via a sulfoxide linkage. Several of the compounds in this class are ANTI-ULCER AGENTS that act by inhibiting the POTASSIUM HYDROGEN ATPASE found in the PROTON PUMP of GASTRIC PARIETAL CELLS.
The act of dilating.
The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice.
A species of baboon in the family CERCOPITHECIDAE, which has a well-studied trilevel social structure consisting of troops, bands, and clans.
Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.
Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides of light metals. SODIUM HYDROXIDE and potassium hydroxide are the most widely used caustic agents in industry. Medically, they have been used externally to remove diseased or dead tissues and destroy warts and small tumors. The accidental ingestion of products (household and industrial) containing caustic ingredients results in thousands of injuries per year.
Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood.
A basic aluminum complex of sulfated sucrose.
A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
The superior portion of the body of the stomach above the level of the cardiac notch.
Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.
A movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction.
Tumors or cancer of the ESOPHAGUS.
Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.
A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.
The S-isomer of omeprazole.
Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body.
By adjusting the quantity and quality of food intake to improve health status of an individual. This term does not include the methods of food intake (NUTRITIONAL SUPPORT).
Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.
Production or presence of gas in the gastrointestinal tract which may be expelled through the anus.
Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
The segment of GASTROINTESTINAL TRACT that includes the ESOPHAGUS; the STOMACH; and the DUODENUM.
A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.
Surgical formation of an opening through the ABDOMINAL WALL into the JEJUNUM, usually for enteral hyperalimentation.
The ejection of gas or air through the mouth from the stomach.
A Y-shaped surgical anastomosis of any part of the digestive system which includes the small intestine as the eventual drainage site.
Pharmacologic agents in the form of a mist or spray delivered into the body through the mouth.
Substances that counteract or neutralize acidity of the GASTROINTESTINAL TRACT.
A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.
An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.
An unnaturally deep or rough quality of voice.
A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
A plant genus of the family LAMIACEAE that is an ingredient of Banxia Houpu (DRUGS, CHINESE HERBAL).
A condition in which there is a change of one adult cell type to another similar adult cell type.
The bottom portion of the pharynx situated below the OROPHARYNX and posterior to the LARYNX. The hypopharynx communicates with the larynx through the laryngeal inlet, and is also called laryngopharynx.
A diet which is devoid of GLUTENS from WHEAT; BARLEY; RYE; and other wheat-related varieties. The diet is designed to reduce exposure to those proteins in gluten that trigger INFLAMMATION of the small intestinal mucosa in patients with CELIAC DISEASE.
Hydrochloric acid present in GASTRIC JUICE.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Organic compounds that have the general formula R-SO-R. They are obtained by oxidation of mercaptans (analogous to the ketones). (From Hackh's Chemical Dictionary, 4th ed)
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.
The total amount of radiation absorbed by tissues as a result of radiotherapy.
The R-isomer of lansoprazole.
Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Preservation of postural control of transient lower oesophageal sphincter relaxations in patients with reflux oesophagitis. (1/319)

INTRODUCTION: In normal subjects, transient lower oesophageal sphincter relaxations (TLOSRs) and gas reflux during belching are suppressed in the supine position. Supine reflux, however, is a feature of reflux disease. AIMS: To investigate whether postural suppression of TLOSRs and gas reflux is impaired in patients with reflux disease. PATIENTS: Ten patients with erosive oesophagitis. METHODS: Oesophageal manometry was performed during gastric distension with 750 ml carbon dioxide. Measurements were made for 10 minutes before and after distension in both sitting and supine positions. RESULTS: In the sitting position gastric distension substantially increased the rate of gas reflux (median (interquartile range)), as evidenced by increases in oesophageal common cavities from 1 (0-1)/10 min to 7 (5-10)/10 min and TLOSRs from 1 (1-1.5)/10 min to 6 (2.5-8)/10 min. However, this effect was suppressed in the supine position in all but one patient (TLOSRs 0 (0)/10 min to 1 (0-4.5)/10 min, common cavities 0 (0)/10 min to 0.5 (0-2)/10 min). CONCLUSIONS: Postural suppression of TLOSRs and gas reflux is generally preserved in reflux disease.  (+info)

Oesophageal epithelial innervation in health and reflux oesophagitis. (2/319)

BACKGROUND: The response of the oesophagus to refluxed gastric contents is likely to depend on intact neural mechanisms in the oesophageal mucosa. The epithelial innervation has not been systematically evaluated in health or reflux disease. AIMS: To study oesophageal epithelial innervation in controls, and also inflamed and non-inflamed mucosa in patients with reflux oesophagitis and healed oesophagitis. PATIENTS: Ten controls, nine patients with reflux oesophagitis, and five patients with healed oesophagitis. METHODS: Oesophageal epithelial biopsy specimens were obtained at endoscopy. The distribution of the neuronal marker protein gene product 9.5 (PGP), and the neuropeptides calcitonin gene related peptide (CGRP), neuropeptide Y (NPY), substance P (SP), and vasoactive intestinal peptide (VIP) were investigated by immunohistochemistry. Density of innervation was assessed by the proportion of papillae in each oesophageal epithelial biopsy specimen containing immunoreactive fibres (found in the subepithelium and epithelial papillae, but not penetrating the epithelium). RESULTS: The proportion of papillae positive for PGP immunoreactive nerve fibres was significantly increased in inflamed tissue when compared with controls, and non-inflamed and healed tissue. There was also a significant increase in VIP immunoreactive fibres within epithelial papillae. Other neuropeptides showed no proportional changes in inflammation. CONCLUSIONS: Epithelial biopsy specimens can be used to assess innervation in the oesophagus. The innervation of the oesophageal mucosa is not altered in non-inflamed tissue of patients with oesophagitis but alters in response to inflammation, where there is a selective increase (about three- to fourfold) in VIP containing nerves.  (+info)

Gastroesophageal reflux disease: diagnosis and management. (3/319)

Gastroesophageal reflux disease (GERD) is a chronic, relapsing condition with associated morbidity and an adverse impact on quality of life. The disease is common, with an estimated lifetime prevalence of 25 to 35 percent in the U.S. population. GERD can usually be diagnosed based on the clinical presentation alone. In some patients, however, the diagnosis may require endoscopy and, rarely, ambulatory pH monitoring. Management includes lifestyle modifications and pharmacologic therapy; refractory disease requires surgery. The therapeutic goals are to control symptoms, heal esophagitis and maintain remission so that morbidity is decreased and quality of life is improved.  (+info)

Responses of the competent and incompetent lower oesophageal sphincter to pentagastrin and abdominal compression. (4/319)

Responses of the lower oesophageal sphincter (LOS) to pentagastrin, given by continuous intravenous infusion in doses ranging between 0 and 9 mug/kg/h, and to external abdominal compression were measured by infused catheters in healthy subjects and in a group of patients with reflux oesophagitis. In separate experiments, pressures were measured both by sensors stationary within the LOS, and by repeated continuous withdrawals of sensors from stomach to distal oesophagus. In normal subjects, doses of pentagastrin within the physiological range (0.9 mug/kg/h) produced modest but statistically significant increases in LOS pressure. By comparison, sphincteric responses in patients with oesophagitis were small and a dose of 4-5 mug/kg/h was the lowest that produced a significant increase in LOS pressure. During abdominal compression increases in LOS pressure did not significantly exceed increases in intragastric pressure in either patients or normal subjects. This was so at all doses of pentagastrin that were tested. Hence, there was no evidence of synergism between the effects of pentagastrin and abdominal compression upon the LOS. We infer from our findings that gastrin does play a modest role in the physiological regulation of human LOS tone. Relative insensitivity of the incompetent LOS to pentagastrin represents, we believe, sphincteric muscle failure. Our results are not consistent with the hypothesis that LOS incompetence is due to loss or impairment of an adaptive response of the LOS to alterations in intra-abdominal pressure.  (+info)

Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. (5/319)

BACKGROUND: Bile acid toxicity has been shown in the gastric, colonic, and hepatic tissues; the effect on oesophageal mucosa is less well known. AIMS: To determine the spectrum of bile acids refluxing in patients with gastro-oesophageal reflux disease and its relation to oesophageal pH using a new technique of combined oesophageal aspiration and pH monitoring. METHODS: Ten asymptomatic subjects and 30 patients with symptoms of gastro-oesophageal reflux disease (minimal mucosal injury, erosive oesophagitis (grade 2 or 3 Savary-Miller), Barrett's oesophagus/stricture; n=10 in each group) underwent 15 hour continuous oesophageal aspiration with simultaneous pH monitoring. Bile acid assay of the oesophageal samples was performed using modified high performance liquid chromatography. RESULTS: The peak bile acid concentration and DeMeester acid scores were significantly higher in the patients with oesophagitis (median bile acid concentration 124 micromol/l; acid score 20.2) and Barrett's oesophagus/stricture (181 micromol/l; 43. 3) than patients with minimal injury (14 micromol/l; 12.5) or controls (0 micromol/l; 11.1). The predominant bile acids detected were cholic, taurocholic, and glycocholic acids but there was a significantly greater proportion of secondary bile acids, deoxycholic and taurodeoxycholic acids, in patients with erosive oesophagitis and Barrett's oesophagus/stricture. Although bile acid reflux episodes occurred at variable pH, a temporal relation existed between reflux of taurine conjugates and oesophageal acid exposure (r=0.58, p=0.009). CONCLUSION: Toxic secondary bile acid fractions have been detected in patients with extensive mucosal damage. Mixed reflux is more harmful than acid reflux alone with possible toxic synergism existing between the taurine conjugates and acid.  (+info)

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. (6/319)

The incidence of adenocarcinoma of the esophagus has been increasing in developing countries over the last three decades and probably reflects a genuine increase in the incidence of its recognized precursor lesion, Barrett's metaplasia. Despite advances in multimodality therapy, the prognosis for invasive esophageal adenocarcinoma is poor. An improved understanding of the molecular biology of this disease may allow improved diagnosis, therapy, and prognosis. We focus on recent developments in the molecular and cell biology of Barrett's metaplasia, a heterogeneous lesion affecting the transitional zone of the gastro-esophageal junction whose associated molecular alterations may vary both in nature and temporally. Early premalignant clones produce biological and genetic heterogeneity as seen by multiple p53 mutations, p16 mutations, aneuploidy, and abnormal methylation resulting in stepwise changes in differentiation, proliferation, and apoptosis, allowing disease progression under selective pressure. Abnormalities in expression of growth factors of the epidermal growth factor family and cell adhesion molecules, especially cadherin/catenin complexes, may occur early in invasion. Exploitation of these molecular events may lead to a more appropriate diagnosis and understanding of these lesions in the future.  (+info)

Helicobacter pylori and smoking: two additive risk factors for organic dyspepsia. (7/319)

The hopes to distinguish between organic and functional dyspepsia on the grounds of the patient's symptomatology have not been fulfilled due to the low specificity of the so-called sinister symptoms. There is increasing evidence accumulating that Helicobacter pylori status and other environmental factors such as smoking have a higher discriminant power. Studies performed in our laboratories testing H. pylori status on gastric biopsy samples have shown that preselection of patients according to smoking habits and H. pylori status has a higher potential in avoiding unnecessary endoscopies in primary care patients as compared to risk factors based on patient complaints. Out of a total population of 282 primary care patients, one out of 24 endoscopies revealed significant pathology such as peptic ulcer or reflux esophagitis in the non-smokers with a negative H. pylori status, but when both risk factors were positive, the percentage rose to one out of every two patients. These observation have largely been confirmed by recent studies where H. pylori status was prospectively assessed prior to endoscopy by highly specific H. pylori serology or 13C breath test analysis.  (+info)

Reflux esophagitis and its relationship to hiatal hernia. (8/319)

We performed this study to evaluate the prevalence of reflux esophagitis and/or hiatal hernia in patients referred to a medical center and to examine the relationship between endoscopic reflux esophagitis and hiatal hernia. The study was carried out in 1,010 patients referred to Yong Dong Severance Hospital for upper gastrointestinal endoscopy because of symptoms related to the gastrointestinal tract from September 1994 to March 1996. The presence of hiatal hernia was defined as a circular extension of the gastric mucosa of 2 cm or more above the diaphragmatic hiatus. Reflux esophagitis was found in 5.3% of patients, hiatal hernia in 4.1%, duodenal ulcer in 7.2% and gastric ulcer in 8.2%. The prevalence rates of reflux esophagitis and hiatal hernia in males were significantly higher than those in females. Thirty-two percent of patients with reflux esophagitis had hiatal hernia. In patients without reflux esophagitis, hiatal hernia was found in only 2.5% (p<0.01). There was no significant association between the presence of hiatal hernia and the degree of esophagitis on endoscopy. Duodenal ulcer was the second most common endoscopic abnormality found in patients with reflux esophagitis. The prevalence rate of reflux esophagitis and/or hiatal hernia at a medical center is relatively low compared to peptic ulcer disease and other reports from the Western countries. Our study confirms the close association between reflux esophagitis and hiatal hernia.  (+info)

Esophagitis is a medical condition characterized by inflammation and irritation of the esophageal lining, which is the muscular tube that connects the throat to the stomach. This inflammation can cause symptoms such as difficulty swallowing, chest pain, heartburn, and acid reflux.

Esophagitis can be caused by various factors, including gastroesophageal reflux disease (GERD), infection, allergies, medications, and chronic vomiting. Prolonged exposure to stomach acid can also cause esophagitis, leading to a condition called reflux esophagitis.

If left untreated, esophagitis can lead to complications such as strictures, ulcers, and Barrett's esophagus, which is a precancerous condition that increases the risk of developing esophageal cancer. Treatment for esophagitis typically involves addressing the underlying cause, managing symptoms, and protecting the esophageal lining to promote healing.

Peptic esophagitis is a medical condition that refers to inflammation and damage of the lining of the esophagus caused by stomach acid backing up into the esophagus. This is also known as gastroesophageal reflux disease (GERD). The term "peptic" indicates that digestive enzymes or stomach acids are involved in the cause of the condition.

Peptic esophagitis can cause symptoms such as heartburn, chest pain, difficulty swallowing, and painful swallowing. If left untreated, it can lead to complications like strictures, ulcers, and Barrett's esophagus, which is a precancerous condition. Treatment typically involves lifestyle changes, medications to reduce acid production, and sometimes surgery.

Eosinophilic esophagagitis (EE) is a chronic, immune-mediated disorder characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation. It's typically diagnosed through endoscopic biopsy that reveals more than 15 eosinophils per high power field in the esophagus, despite treatment for gastroesophageal reflux disease (GERD).

Eosinophils are a type of white blood cell that play an important role in the body's immune response. In EE, these cells accumulate in the esophagus and cause inflammation, leading to symptoms such as difficulty swallowing (dysphagia), food impaction, chest pain, heartburn, and regurgitation.

The disorder is often associated with other atopic conditions, such as asthma, allergic rhinitis, and eczema. Treatment typically involves a combination of dietary modifications, medications (such as proton pump inhibitors or corticosteroids), and esophageal dilation in cases where there is stricture formation.

The esophagus is the muscular tube that connects the throat (pharynx) to the stomach. It is located in the midline of the neck and chest, passing through the diaphragm to enter the abdomen and join the stomach. The main function of the esophagus is to transport food and liquids from the mouth to the stomach for digestion.

The esophagus has a few distinct parts: the upper esophageal sphincter (a ring of muscle that separates the esophagus from the throat), the middle esophagus, and the lower esophageal sphincter (another ring of muscle that separates the esophagus from the stomach). The lower esophageal sphincter relaxes to allow food and liquids to enter the stomach and then contracts to prevent stomach contents from flowing back into the esophagus.

The walls of the esophagus are made up of several layers, including mucosa (a moist tissue that lines the inside of the tube), submucosa (a layer of connective tissue), muscle (both voluntary and involuntary types), and adventitia (an outer layer of connective tissue).

Common conditions affecting the esophagus include gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal cancer, esophageal strictures, and eosinophilic esophagitis.

Esophagoscopy is a medical procedure that involves the visual examination of the esophagus, which is the tube that connects the throat to the stomach. This procedure is typically carried out using an esophagogastroduodenoscope (EGD), a flexible tube with a camera and light on the end.

During the procedure, the EGD is inserted through the mouth and down the throat into the esophagus, allowing the medical professional to examine its lining for any abnormalities such as inflammation, ulcers, or tumors. The procedure may also involve taking tissue samples (biopsies) for further examination and testing.

Esophagoscopy is commonly used to diagnose and monitor conditions such as gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal cancer, and other disorders affecting the esophagus. It may also be used to treat certain conditions, such as removing polyps or foreign objects from the esophagus.

Gastroesophageal reflux (GER) is the retrograde movement of stomach contents into the esophagus, which can cause discomfort and symptoms. It occurs when the lower esophageal sphincter (a ring of muscle between the esophagus and stomach) relaxes inappropriately, allowing the acidic or non-acidic gastric contents to flow back into the esophagus.

Gastroesophageal reflux becomes gastroesophageal reflux disease (GERD) when it is more severe, persistent, and/or results in complications such as esophagitis, strictures, or Barrett's esophagus. Common symptoms of GERD include heartburn, regurgitation, chest pain, difficulty swallowing, and chronic cough or hoarseness.

A hiatal hernia is a type of hernia that occurs when a part of the stomach protrudes or squeezes through an opening (hiatus) in the diaphragm, the muscular partition between the chest and abdominal cavities. Normally, the esophagus passes through this opening to connect to the stomach, but in a hiatal hernia, a portion of the stomach also moves up into the chest cavity through the hiatus.

There are two main types of hiatal hernias: sliding and paraesophageal. In a sliding hiatal hernia, the junction between the esophagus and stomach (gastroesophageal junction) slides upward into the chest cavity, which is the most common type. Paraesophageal hiatal hernias are less common but can be more severe, as they involve the stomach herniating alongside the esophagus, potentially leading to complications like obstruction or strangulation of the blood supply to the stomach.

Many people with hiatal hernias do not experience symptoms, but some may have heartburn, acid reflux, regurgitation, difficulty swallowing, chest pain, or shortness of breath. Treatment depends on the severity and associated symptoms, ranging from lifestyle modifications and medications to surgical repair in severe cases.

Eosinophilia is a medical condition characterized by an abnormally high concentration of eosinophils in the circulating blood. Eosinophils are a type of white blood cell that play an important role in the immune system, particularly in fighting off parasitic infections and regulating allergic reactions. However, when their numbers become excessively high, they can contribute to tissue damage and inflammation.

Eosinophilia is typically defined as a count of more than 500 eosinophils per microliter of blood. Mild eosinophilia (up to 1,500 cells/μL) may not cause any symptoms and may be discovered during routine blood tests. However, higher levels of eosinophilia can lead to various symptoms such as coughing, wheezing, skin rashes, and organ damage, depending on the underlying cause.

The causes of eosinophilia are varied and can include allergic reactions, parasitic infections, autoimmune disorders, certain medications, and some types of cancer. Accurate diagnosis and treatment of eosinophilia require identification and management of the underlying cause.

Esophageal stenosis is a medical condition characterized by the narrowing or constriction of the esophagus, which is the muscular tube that connects the throat to the stomach. This narrowing can make it difficult to swallow food and liquids, leading to symptoms such as dysphagia (difficulty swallowing), pain or discomfort while swallowing, regurgitation, and weight loss.

Esophageal stenosis can be caused by a variety of factors, including:

1. Scarring or fibrosis due to prolonged acid reflux or gastroesophageal reflux disease (GERD)
2. Radiation therapy for cancer treatment
3. Ingestion of corrosive substances
4. Eosinophilic esophagitis, an allergic condition that affects the esophagus
5. Esophageal tumors or cancers
6. Surgical complications

Depending on the underlying cause and severity of the stenosis, treatment options may include medications to manage symptoms, dilation procedures to widen the narrowed area, or surgery to remove the affected portion of the esophagus. It is important to seek medical attention if you experience any difficulty swallowing or other symptoms related to esophageal stenosis.

Barrett esophagus is a condition in which the tissue lining of the lower esophagus changes, becoming more like the tissue that lines the intestines (intestinal metaplasia). This change can increase the risk of developing esophageal adenocarcinoma, a type of cancer. The exact cause of Barrett esophagus is not known, but it is often associated with long-term gastroesophageal reflux disease (GERD), also known as chronic acid reflux.

In Barrett esophagus, the normal squamous cells that line the lower esophagus are replaced by columnar epithelial cells. This change is usually detected during an upper endoscopy and biopsy. The diagnosis of Barrett esophagus is confirmed when the biopsy shows intestinal metaplasia in the lower esophagus.

It's important to note that not everyone with GERD will develop Barrett esophagus, and not everyone with Barrett esophagus will develop esophageal cancer. However, if you have been diagnosed with Barrett esophagus, your healthcare provider may recommend regular endoscopies and biopsies to monitor the condition and reduce the risk of cancer. Treatment options for Barrett esophagus include medications to control acid reflux, lifestyle changes, and in some cases, surgery.

Gastrointestinal endoscopy is a medical procedure that allows direct visualization of the inner lining of the digestive tract, which includes the esophagus, stomach, small intestine, large intestine (colon), and sometimes the upper part of the small intestine (duodenum). This procedure is performed using an endoscope, a long, thin, flexible tube with a light and camera at its tip. The endoscope is inserted through the mouth for upper endoscopy or through the rectum for lower endoscopy (colonoscopy), and the images captured by the camera are transmitted to a monitor for the physician to view.

Gastrointestinal endoscopy can help diagnose various conditions, such as inflammation, ulcers, tumors, polyps, or bleeding in the digestive tract. It can also be used for therapeutic purposes, such as removing polyps, taking tissue samples (biopsies), treating bleeding, and performing other interventions to manage certain digestive diseases.

There are different types of gastrointestinal endoscopy procedures, including:

1. Upper Endoscopy (Esophagogastroduodenoscopy or EGD): This procedure examines the esophagus, stomach, and duodenum.
2. Colonoscopy: This procedure examines the colon and rectum.
3. Sigmoidoscopy: A limited examination of the lower part of the colon (sigmoid colon) using a shorter endoscope.
4. Enteroscopy: An examination of the small intestine, which can be performed using various techniques, such as push enteroscopy, single-balloon enteroscopy, or double-balloon enteroscopy.
5. Capsule Endoscopy: A procedure that involves swallowing a small capsule containing a camera, which captures images of the digestive tract as it passes through.

Gastrointestinal endoscopy is generally considered safe when performed by experienced medical professionals. However, like any medical procedure, there are potential risks and complications, such as bleeding, infection, perforation, or adverse reactions to sedatives used during the procedure. Patients should discuss these risks with their healthcare provider before undergoing gastrointestinal endoscopy.

Deglutition disorders, also known as swallowing disorders, are conditions that affect the ability to move food or liquids from the mouth to the stomach safely and efficiently. These disorders can occur at any stage of the swallowing process, which includes oral preparation (chewing and manipulating food in the mouth), pharyngeal phase (activating muscles and structures in the throat to move food toward the esophagus), and esophageal phase (relaxing and contracting the esophagus to propel food into the stomach).

Symptoms of deglutition disorders may include coughing or choking during or after eating, difficulty initiating a swallow, food sticking in the throat or chest, regurgitation, unexplained weight loss, and aspiration (inhaling food or liquids into the lungs), which can lead to pneumonia.

Deglutition disorders can be caused by various factors, such as neurological conditions (e.g., stroke, Parkinson's disease, multiple sclerosis), structural abnormalities (e.g., narrowing or blockage of the esophagus), muscle weakness or dysfunction, and cognitive or behavioral issues. Treatment for deglutition disorders may involve dietary modifications, swallowing exercises, medications, or surgical interventions, depending on the underlying cause and severity of the condition.

Esophageal pH monitoring is a medical test used to measure the acidity (pH level) inside the esophagus. The test involves inserting a thin, flexible tube through the nose and down into the esophagus. The tube contains a sensor that detects changes in pH levels and transmits this information to a recording device worn by the patient.

The test typically lasts for 24 hours, during which time the patient keeps a diary of their activities and symptoms. This information is used to correlate any symptoms with changes in pH levels. The test can help diagnose gastroesophageal reflux disease (GERD) and assess the effectiveness of treatment.

It's important to note that there are some precautions to be taken before and after the test, such as avoiding certain medications that may affect the pH levels or interfere with the test results. Patients should follow their healthcare provider's instructions carefully to ensure accurate results.

Endoscopy of the digestive system, also known as gastrointestinal (GI) endoscopy, is a medical procedure that allows healthcare professionals to visually examine the inside lining of the digestive tract using a flexible tube with a light and camera attached to it, called an endoscope. This procedure can help diagnose and treat various conditions affecting the digestive system, including gastroesophageal reflux disease (GERD), ulcers, inflammatory bowel disease (IBD), and cancer.

There are several types of endoscopy procedures that focus on different parts of the digestive tract:

1. Esophagogastroduodenoscopy (EGD): This procedure examines the esophagus, stomach, and duodenum (the first part of the small intestine). It is often used to investigate symptoms such as difficulty swallowing, abdominal pain, or bleeding in the upper GI tract.
2. Colonoscopy: This procedure explores the large intestine (colon) and rectum. It is commonly performed to screen for colon cancer, as well as to diagnose and treat conditions like inflammatory bowel disease, diverticulosis, or polyps.
3. Sigmoidoscopy: Similar to a colonoscopy, this procedure examines the lower part of the colon (sigmoid colon) and rectum. It is often used as a screening tool for colon cancer and to investigate symptoms like rectal bleeding or changes in bowel habits.
4. Upper GI endoscopy: This procedure focuses on the esophagus, stomach, and duodenum, using a thin, flexible tube with a light and camera attached to it. It is used to diagnose and treat conditions such as GERD, ulcers, and difficulty swallowing.
5. Capsule endoscopy: This procedure involves swallowing a small capsule containing a camera that captures images of the digestive tract as it passes through. It can help diagnose conditions in the small intestine that may be difficult to reach with traditional endoscopes.

Endoscopy is typically performed under sedation or anesthesia to ensure patient comfort during the procedure. The images captured by the endoscope are displayed on a monitor, allowing the healthcare provider to assess the condition of the digestive tract and make informed treatment decisions.

Heartburn is not a cardiac condition, but rather a digestive disorder. The medical term for heartburn is "pyrosis." It is characterized by a burning sensation in the chest or throat, caused by the reflux of stomach acid into the esophagus. This backflow of acid can irritate the lining of the esophagus, leading to discomfort and pain. Heartburn often occurs after eating, when lying down, or during bending over, and it can be worsened by certain foods, drinks, or medications. Chronic or severe heartburn may indicate a more serious condition, such as gastroesophageal reflux disease (GERD).

Proton pump inhibitors (PPIs) are a class of medications that work to reduce gastric acid production by blocking the action of proton pumps in the parietal cells of the stomach. These drugs are commonly used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions where excessive stomach acid is a problem.

PPIs include several different medications such as omeprazole, lansoprazole, rabeprazole, pantoprazole, and esomeprazole. They are usually taken orally, but some PPIs are also available in intravenous (IV) form for hospital use.

By inhibiting the action of proton pumps, PPIs reduce the amount of acid produced in the stomach, which can help to relieve symptoms such as heartburn, chest pain, and difficulty swallowing. They are generally considered safe and effective when used as directed, but long-term use may increase the risk of certain side effects, including bone fractures, vitamin B12 deficiency, and Clostridium difficile infection.

A mucous membrane is a type of moist, protective lining that covers various body surfaces inside the body, including the respiratory, gastrointestinal, and urogenital tracts, as well as the inner surface of the eyelids and the nasal cavity. These membranes are composed of epithelial cells that produce mucus, a slippery secretion that helps trap particles, microorganisms, and other foreign substances, preventing them from entering the body or causing damage to tissues. The mucous membrane functions as a barrier against infection and irritation while also facilitating the exchange of gases, nutrients, and waste products between the body and its environment.

Manometry is a medical test that measures pressure inside various parts of the gastrointestinal tract. It is often used to help diagnose digestive disorders such as achalasia, gastroparesis, and irritable bowel syndrome. During the test, a thin, flexible tube called a manometer is inserted through the mouth or rectum and into the area being tested. The tube is connected to a machine that measures and records pressure readings. These readings can help doctors identify any abnormalities in muscle function or nerve reflexes within the digestive tract.

Esophageal motility disorders are a group of conditions that affect the normal movement (motility) of the muscles in the esophagus, which is the tube that connects the throat to the stomach. The esophageal muscles normally contract and relax in a coordinated manner to help move food from the mouth to the stomach.

In esophageal motility disorders, this muscle movement is impaired, leading to difficulty swallowing (dysphagia), chest pain, heartburn, or regurgitation of food. Some common examples of esophageal motility disorders include:

1. Achalasia: a condition in which the lower esophageal sphincter muscle fails to relax properly, preventing food from passing into the stomach.
2. Diffuse esophageal spasm: a disorder characterized by uncoordinated contractions of the esophageal muscles, leading to difficulty swallowing and chest pain.
3. Nutcracker esophagus: a condition in which the esophageal muscles contract too forcefully, causing pain and difficulty swallowing.
4. Hypertensive lower esophageal sphincter: a disorder in which the lower esophageal sphincter muscle is too tight, making it difficult to swallow and leading to symptoms such as heartburn and regurgitation.
5. Ineffective esophageal motility: a condition in which the esophageal muscles have weak or disorganized contractions, leading to difficulty swallowing and other symptoms.

Esophageal motility disorders can be diagnosed through tests such as manometry, which measures the pressure and coordination of esophageal muscle contractions, or barium swallow studies, which use X-rays to visualize the movement of food through the esophagus. Treatment may include medications, lifestyle changes, or surgery, depending on the specific disorder and its severity.

"Papio cynocephalus" is a scientific name for a species of old world monkey, commonly known as the yellow baboon. It's not typically used in a medical context, but I can provide some general biological information about it if that would be helpful.

Yellow baboons are native to the savannas and woodlands of eastern and southern Africa. They have a distinct appearance with a dog-like face (hence the species name "cynocephalus," which means "dog-headed" in Greek) and a long, close-set coat that is yellowish-brown or olive green in color. Adult males can weigh between 33 to 82 pounds (15 to 37 kg), while females are smaller and typically weigh between 14 to 33 pounds (6 to 15 kg).

Yellow baboons live in large social groups called troops, which can consist of up to 200 individuals. They have a complex hierarchical social structure based on age, sex, and dominance. Their diet is omnivorous, consisting of fruits, seeds, nuts, insects, and small vertebrates.

In terms of medical relevance, yellow baboons are sometimes used as animal models in biomedical research due to their close genetic relationship with humans (they share about 96% of their DNA sequence with us). However, it's important to note that using non-human primates in research is a controversial topic and subject to ethical considerations.

Gastroscopy is a medical procedure that involves the insertion of a gastroscope, which is a thin, flexible tube with a camera and light on the end, through the mouth and into the digestive tract. The gastroscope allows the doctor to visually examine the lining of the esophagus, stomach, and duodenum (the first part of the small intestine) for any abnormalities such as inflammation, ulcers, or tumors.

The procedure is usually performed under sedation to minimize discomfort, and it typically takes only a few minutes to complete. Gastroscopy can help diagnose various conditions, including gastroesophageal reflux disease (GERD), gastritis, stomach ulcers, and Barrett's esophagus. It can also be used to take tissue samples for biopsy or to treat certain conditions, such as bleeding or the removal of polyps.

Anti-ulcer agents are a class of medications that are used to treat and prevent ulcers in the gastrointestinal tract. These medications work by reducing the production of stomach acid, neutralizing stomach acid, or protecting the lining of the stomach and duodenum from damage caused by stomach acid.

There are several types of anti-ulcer agents, including:

1. Proton pump inhibitors (PPIs): These medications block the action of proton pumps in the stomach, which are responsible for producing stomach acid. PPIs include drugs such as omeprazole, lansoprazole, and pantoprazole.
2. H-2 receptor antagonists: These medications block the action of histamine on the H-2 receptors in the stomach, reducing the production of stomach acid. Examples include ranitidine, famotidine, and cimetidine.
3. Antacids: These medications neutralize stomach acid and provide quick relief from symptoms such as heartburn and indigestion. Common antacids include calcium carbonate, magnesium hydroxide, and aluminum hydroxide.
4. Protective agents: These medications form a barrier between the stomach lining and stomach acid, protecting the lining from damage. Examples include sucralfate and misoprostol.

Anti-ulcer agents are used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. It is important to take these medications as directed by a healthcare provider, as they can have side effects and interactions with other medications.

Omeprazole is defined as a proton pump inhibitor (PPI) used in the treatment of gastroesophageal reflux disease (GERD), gastric ulcers, and other conditions where reducing stomach acid is desired. It works by blocking the action of the proton pumps in the stomach, which are responsible for producing stomach acid. By inhibiting these pumps, omeprazole reduces the amount of acid produced in the stomach, providing relief from symptoms such as heartburn and pain caused by excess stomach acid.

It is available in various forms, including tablets, capsules, and oral suspension, and is typically taken once or twice a day, depending on the condition being treated. As with any medication, omeprazole should be used under the guidance of a healthcare professional, and its potential side effects and interactions with other medications should be carefully considered before use.

Laryngopharyngeal reflux (LPR) is a condition in which the stomach contents, particularly acid, flow backward from the stomach into the larynx (voice box) and pharynx (throat). This is also known as extraesophageal reflux disease (EERD) or supraesophageal reflux disease (SERD). Unlike gastroesophageal reflux disease (GERD), where acid reflux causes symptoms such as heartburn and regurgitation, LPR may not cause classic reflux symptoms, but rather symptoms related to the upper aerodigestive tract. These can include hoarseness, throat clearing, cough, difficulty swallowing, and a sensation of a lump in the throat.

The lower esophageal sphincter (LES) is a specialized ring of muscle located at the junction of the esophagus and stomach. It functions as a physiological valve that regulates the direction of content flow between the esophagus and the stomach. Normally, the LES remains contracted to prevent the reflux of gastric contents into the esophagus, and it relaxes during swallowing to allow food to enter the stomach.

A dysfunctional lower esophageal sphincter may lead to gastroesophageal reflux disease (GERD), where stomach acid frequently backs up into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.

Esophageal diseases refer to a range of medical conditions that affect the esophagus, which is the muscular tube that connects the throat to the stomach. Here are some common esophageal diseases with their brief definitions:

1. Gastroesophageal reflux disease (GERD): A chronic condition in which stomach acid or bile flows back into the esophagus, causing symptoms such as heartburn, chest pain, and difficulty swallowing.
2. Esophagitis: Inflammation of the esophageal lining, often caused by GERD, infection, or medication.
3. Esophageal stricture: Narrowing of the esophagus due to scarring or inflammation, which can make swallowing difficult.
4. Esophageal cancer: Cancer that forms in the tissues of the esophagus, often as a result of long-term GERD or smoking.
5. Esophageal motility disorders: Disorders that affect the normal movement and function of the esophagus, such as achalasia, diffuse spasm, and nutcracker esophagus.
6. Barrett's esophagus: A condition in which the lining of the lower esophagus changes, increasing the risk of esophageal cancer.
7. Esophageal diverticula: Small pouches that form in the esophageal wall, often causing difficulty swallowing or regurgitation.
8. Eosinophilic esophagitis (EoE): A chronic immune-mediated disorder characterized by inflammation of the esophagus due to an allergic reaction.

These are some of the common esophageal diseases, and their diagnosis and treatment may vary depending on the severity and underlying cause of the condition.

Duodenogastric reflux (DGR) is a medical condition in which the contents of the duodenum, the first part of the small intestine, flow backward into the stomach. This occurs when the pyloric sphincter, a muscle that separates the stomach and duodenum, fails to function properly, allowing the reflux of duodenal juice into the stomach.

Duodenogastric refluxate typically contains bile acids, digestive enzymes, and other stomach-irritating substances. Chronic DGR can lead to gastritis (inflammation of the stomach lining), ulcers, and other gastrointestinal complications. Symptoms may include abdominal pain, bloating, nausea, vomiting, heartburn, and indigestion. Treatment usually involves medications that reduce acid production or neutralize stomach acid, as well as lifestyle modifications to minimize reflux triggers.

Fundoplication is a surgical procedure in which the upper part of the stomach (the fundus) is wrapped around the lower esophagus and then stitched into place. This procedure strengthens the lower esophageal sphincter, which helps prevent acid reflux from the stomach into the esophagus. It is commonly used to treat gastroesophageal reflux disease (GERD) and paraesophageal hernias.

2-Pyridinylmethylsulfinylbenzimidazoles is a class of chemical compounds that have both a pyridinylmethylsulfinyl group and a benzimidazole ring in their structure. Pyridinylmethylsulfinyl refers to a functional group consisting of a sulfinyl group (-S(=O)-) attached to a methyl group (-CH2-) that is, in turn, attached to a pyridine ring. Benzimidazoles are heterocyclic compounds containing a fused benzene and imidazole ring.

These types of compounds have been studied for their potential biological activity, including anti-inflammatory, antiviral, and antitumor properties. However, it's important to note that medical definitions typically refer to specific substances or classes of substances that have established clinical use or are under investigation for therapeutic purposes. As such, 2-Pyridinylmethylsulfinylbenzimidazoles do not have a recognized medical definition in this sense.

Dilation, also known as dilatation, refers to the process of expanding or enlarging a body passage or cavity. In medical terms, it typically refers to the widening of a bodily opening or hollow organ, allowing for increased flow or access. This can occur naturally, such as during childbirth when the cervix dilates to allow for the passage of a baby, or it can be induced through medical procedures or interventions.

For example, dilation of the pupils is a natural response to darkness or certain medications, while dilation of blood vessels is a common side effect of some drugs and can also occur in response to changes in temperature or emotional state. Dilation of the stomach or intestines may be necessary for medical procedures such as endoscopies or surgeries.

It's important to note that dilation can also refer to the abnormal enlargement of a body part, such as dilated cardiomyopathy, which refers to an enlarged and weakened heart muscle.

The esophagogastric junction (EGJ) is the region of the gastrointestinal tract where the esophagus (the tube that carries food from the mouth to the stomach) meets the stomach. It serves as a physiological sphincter, which helps control the direction of flow and prevent reflux of gastric contents back into the esophagus. The EGJ is also known as the gastroesophageal junction or cardia.

"Papio hamadryas" is a species of old world monkey, also known as the Hamadryas baboon. It is not a medical term or concept. Here's a brief overview of its biological significance:

The Hamadryas baboon (Papio hamadryas) is native to the Horn of Africa and the southwestern Arabian Peninsula. They are highly social primates, living in large groups called troops. These troops can consist of hundreds of individuals, but they are hierarchically structured with multiple adult males, harems of females, and their offspring.

Hamadryas baboons have a distinctive appearance, characterized by their dog-like faces, hairless calluses on their rumps, and long, flowing manes. They primarily feed on plants, but they are also known to consume small vertebrates and invertebrates. Their gestation period is approximately six months, and females typically give birth to a single offspring.

In captivity, Hamadryas baboons have been used as subjects in various biomedical research studies due to their close phylogenetic relationship with humans. However, the term 'Papio hamadryas' itself does not have a medical definition.

Endoscopy is a medical procedure that involves the use of an endoscope, which is a flexible tube with a light and camera at the end, to examine the interior of a body cavity or organ. The endoscope is inserted through a natural opening in the body, such as the mouth or anus, or through a small incision. The images captured by the camera are transmitted to a monitor, allowing the physician to visualize the internal structures and detect any abnormalities, such as inflammation, ulcers, or tumors. Endoscopy can also be used for diagnostic purposes, such as taking tissue samples for biopsy, or for therapeutic purposes, such as removing polyps or performing minimally invasive surgeries.

In medical terms, "caustics" refer to substances that can cause burns or destroy living tissue due to their corrosive nature. They can cause chemical burns upon contact with skin, eyes, or mucous membranes, leading to inflammation, necrosis (tissue death), and potential scarring. Common caustic substances include strong acids and bases, such as sulfuric acid, hydrochloric acid, and sodium hydroxide (lye).

In dermatology, the term "caustics" may also refer to chemical peeling agents used for the treatment of various skin conditions, such as hyperpigmentation, acne scars, or fine lines. These substances, which include trichloroacetic acid (TCA) and phenol, cause a controlled injury to the skin, leading to exfoliation and the stimulation of new tissue growth. However, they must be used with caution, as improper application can result in unwanted side effects or complications.

Histamine H2 antagonists, also known as H2 blockers, are a class of medications that work by blocking the action of histamine on the H2 receptors in the stomach. Histamine is a chemical that is released by the body during an allergic reaction and can also be released by certain cells in the stomach in response to food or other stimuli. When histamine binds to the H2 receptors in the stomach, it triggers the release of acid. By blocking the action of histamine on these receptors, H2 antagonists reduce the amount of acid produced by the stomach, which can help to relieve symptoms such as heartburn, indigestion, and stomach ulcers. Examples of H2 antagonists include ranitidine (Zantac), famotidine (Pepcid), and cimetidine (Tagamet).

Sucralfate is a medication that belongs to a class of drugs called aluminum complexes. It's often used in the treatment of gastrointestinal ulcers, including duodenal and gastric ulcers, as well as in the prevention of stress-induced mucosal damage in critically ill patients.

Sucralfate works by forming a protective barrier over the ulcer site, which helps to prevent further damage from acid and digestive enzymes. It's not absorbed into the bloodstream, so it acts locally in the gastrointestinal tract. The medical definition of Sucralfate is:

A synthetic basic aluminum salt of sucrose octasulfate, which is used in the treatment of gastro duodenal ulcers and as a protectant against stress-induced mucosal damage in critically ill patients. It exerts its therapeutic effect by forming a complex, adhesive protective coating over ulcerated areas, thereby preventing further erosion from gastric acid and pepsin.

Lansoprazole is a medication that belongs to a class of drugs called proton pump inhibitors (PPIs). It works by reducing the amount of acid produced in the stomach. The medical definition of Lansoprazole is:

A substituted benzimidazole that is a selective gastric proton pump inhibitor, which suppresses gastric acid secretion by specific inhibition of the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell. It is used as an effective therapy for various gastrointestinal disorders, including gastric and duodenal ulcers, erosive esophagitis, and gastroesophageal reflux disease (GERD). Lansoprazole is available in the form of capsules or oral granules for delayed-release oral administration.

Here's a brief overview of its mechanism of action:

* Lansoprazole is absorbed into the bloodstream and transported to the parietal cells in the stomach, where it is converted into its active form.
* The active form of lansoprazole binds to and inhibits the H+/K+ ATPase enzyme system, which is responsible for pumping hydrogen ions (protons) from the cytoplasm of the parietal cell into the lumen of the stomach, where they combine with chloride ions to form hydrochloric acid.
* By inhibiting this proton pump, lansoprazole reduces the amount of acid produced in the stomach, which helps to relieve symptoms and promote healing of gastrointestinal disorders.

The gastric fundus is the upper, rounded portion of the stomach that lies above the level of the cardiac orifice and extends up to the left dome-shaped part of the diaphragm. It is the part of the stomach where food and liquids are first stored after entering through the esophagus. The gastric fundus contains parietal cells, which secrete hydrochloric acid, and chief cells, which produce pepsinogen, a precursor to the digestive enzyme pepsin. It is also the site where the hormone ghrelin is produced, which stimulates appetite.

Radiation injuries refer to the damages that occur to living tissues as a result of exposure to ionizing radiation. These injuries can be acute, occurring soon after exposure to high levels of radiation, or chronic, developing over a longer period after exposure to lower levels of radiation. The severity and type of injury depend on the dose and duration of exposure, as well as the specific tissues affected.

Acute radiation syndrome (ARS), also known as radiation sickness, is the most severe form of acute radiation injury. It can cause symptoms such as nausea, vomiting, diarrhea, fatigue, fever, and skin burns. In more severe cases, it can lead to neurological damage, hemorrhage, infection, and death.

Chronic radiation injuries, on the other hand, may not appear until months or even years after exposure. They can cause a range of symptoms, including fatigue, weakness, skin changes, cataracts, reduced fertility, and an increased risk of cancer.

Radiation injuries can be treated with supportive care, such as fluids and electrolytes replacement, antibiotics, wound care, and blood transfusions. In some cases, surgery may be necessary to remove damaged tissue or control bleeding. Prevention is the best approach to radiation injuries, which includes limiting exposure through proper protective measures and monitoring radiation levels in the environment.

Peristalsis is an involuntary muscular movement that occurs in the digestive tract, including the esophagus, stomach, and intestines. It is characterized by alternate contraction and relaxation of the smooth muscles in the walls of these organs, which creates a wave-like motion that helps propel food, fluids, and waste through the digestive system.

The process of peristalsis begins with a narrowing or constriction of the muscle in one area of the digestive tract, followed by a relaxation of the muscle in the adjacent area. This creates a localized contraction that moves along the length of the organ, pushing its contents forward. The wave of contractions continues to move along the digestive tract until it reaches the anus, where waste is eliminated from the body.

Peristalsis plays a crucial role in maintaining proper digestion and absorption of nutrients, as well as in the elimination of waste products from the body. Disorders that affect peristalsis, such as gastrointestinal motility disorders, can lead to symptoms such as abdominal pain, bloating, constipation, or diarrhea.

Esophageal neoplasms refer to abnormal growths in the tissue of the esophagus, which is the muscular tube that connects the throat to the stomach. These growths can be benign (non-cancerous) or malignant (cancerous). Malignant esophageal neoplasms are typically classified as either squamous cell carcinomas or adenocarcinomas, depending on the type of cell from which they originate.

Esophageal cancer is a serious and often life-threatening condition that can cause symptoms such as difficulty swallowing, chest pain, weight loss, and coughing. Risk factors for esophageal neoplasms include smoking, heavy alcohol consumption, gastroesophageal reflux disease (GERD), and Barrett's esophagus. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Food hypersensitivity is an umbrella term that encompasses both immunologic and non-immunologic adverse reactions to food. It is also known as "food allergy" or "food intolerance." Food hypersensitivity occurs when the body's immune system or digestive system reacts negatively to a particular food or food component.

Immunologic food hypersensitivity, commonly referred to as a food allergy, involves an immune response mediated by immunoglobulin E (IgE) antibodies. Upon ingestion of the offending food, IgE antibodies bind to the food antigens and trigger the release of histamine and other chemical mediators from mast cells and basophils, leading to symptoms such as hives, swelling, itching, difficulty breathing, or anaphylaxis.

Non-immunologic food hypersensitivity, on the other hand, does not involve the immune system. Instead, it is caused by various mechanisms, including enzyme deficiencies, pharmacological reactions, and metabolic disorders. Examples of non-immunologic food hypersensitivities include lactose intolerance, gluten sensitivity, and histamine intolerance.

It's important to note that the term "food hypersensitivity" is often used interchangeably with "food allergy," but it has a broader definition that includes both immunologic and non-immunologic reactions.

Hydrochloric acid, also known as muriatic acid, is not a substance that is typically found within the human body. It is a strong mineral acid with the chemical formula HCl. In a medical context, it might be mentioned in relation to gastric acid, which helps digest food in the stomach. Gastric acid is composed of hydrochloric acid, potassium chloride and sodium chloride dissolved in water. The pH of hydrochloric acid is very low (1-2) due to its high concentration of H+ ions, making it a strong acid. However, it's important to note that the term 'hydrochloric acid' does not directly refer to a component of human bodily fluids or tissues.

Esomeprazole is a medication that belongs to a class of drugs called proton pump inhibitors (PPIs). It works by reducing the amount of acid produced in the stomach. Esomeprazole is used to treat gastroesophageal reflux disease (GERD) and other conditions in which the stomach produces too much acid. It is also used to promote healing of erosive esophagitis, a condition in which the esophagus becomes damaged by stomach acid.

Esomeprazole is available in delayed-release capsule and suspension forms, and it is typically taken once a day. It may be prescribed or taken over-the-counter. Common side effects of esomeprazole include headache, diarrhea, nausea, and stomach pain.

It's important to note that long-term use of PPIs like esomeprazole has been associated with an increased risk of certain health problems, such as bone fractures, vitamin B12 deficiency, and Clostridium difficile infection. As with any medication, it is important to follow your healthcare provider's instructions carefully when taking esomeprazole.

A biopsy is a medical procedure in which a small sample of tissue is taken from the body to be examined under a microscope for the presence of disease. This can help doctors diagnose and monitor various medical conditions, such as cancer, infections, or autoimmune disorders. The type of biopsy performed will depend on the location and nature of the suspected condition. Some common types of biopsies include:

1. Incisional biopsy: In this procedure, a surgeon removes a piece of tissue from an abnormal area using a scalpel or other surgical instrument. This type of biopsy is often used when the lesion is too large to be removed entirely during the initial biopsy.

2. Excisional biopsy: An excisional biopsy involves removing the entire abnormal area, along with a margin of healthy tissue surrounding it. This technique is typically employed for smaller lesions or when cancer is suspected.

3. Needle biopsy: A needle biopsy uses a thin, hollow needle to extract cells or fluid from the body. There are two main types of needle biopsies: fine-needle aspiration (FNA) and core needle biopsy. FNA extracts loose cells, while a core needle biopsy removes a small piece of tissue.

4. Punch biopsy: In a punch biopsy, a round, sharp tool is used to remove a small cylindrical sample of skin tissue. This type of biopsy is often used for evaluating rashes or other skin abnormalities.

5. Shave biopsy: During a shave biopsy, a thin slice of tissue is removed from the surface of the skin using a sharp razor-like instrument. This technique is typically used for superficial lesions or growths on the skin.

After the biopsy sample has been collected, it is sent to a laboratory where a pathologist will examine the tissue under a microscope and provide a diagnosis based on their findings. The results of the biopsy can help guide further treatment decisions and determine the best course of action for managing the patient's condition.

Diet therapy is a medical treatment that involves using specific dietary modifications to manage or treat various medical conditions. This can include changing the types and amounts of food consumed, as well as adjusting the timing and frequency of meals. The goal of diet therapy is to provide the body with the necessary nutrients to support healing and maintain health while also addressing any specific dietary needs or restrictions related to a particular medical condition.

Diet therapy may be used to treat a wide range of conditions, including diabetes, heart disease, high blood pressure, obesity, food allergies and intolerances, gastrointestinal disorders, and kidney disease. For example, a person with diabetes may be placed on a diet that restricts sugar and simple carbohydrates to help manage their blood sugar levels, while a person with heart disease may be advised to follow a low-fat, high-fiber diet to reduce their risk of heart attack and stroke.

Diet therapy is often used in conjunction with other medical treatments, such as medication and surgery, and should be prescribed and monitored by a healthcare professional, such as a registered dietitian or a doctor who specializes in nutrition. It is important for individuals to follow their specific dietary recommendations closely in order to achieve the best possible outcomes.

Eosinophils are a type of white blood cell that play an important role in the body's immune response. They are produced in the bone marrow and released into the bloodstream, where they can travel to different tissues and organs throughout the body. Eosinophils are characterized by their granules, which contain various proteins and enzymes that are toxic to parasites and can contribute to inflammation.

Eosinophils are typically associated with allergic reactions, asthma, and other inflammatory conditions. They can also be involved in the body's response to certain infections, particularly those caused by parasites such as worms. In some cases, elevated levels of eosinophils in the blood or tissues (a condition called eosinophilia) can indicate an underlying medical condition, such as a parasitic infection, autoimmune disorder, or cancer.

Eosinophils are named for their staining properties - they readily take up eosin dye, which is why they appear pink or red under the microscope. They make up only about 1-6% of circulating white blood cells in healthy individuals, but their numbers can increase significantly in response to certain triggers.

Flatulence is the medical term for the release of intestinal gas from the rectum, commonly known as passing gas or farting. It is a normal bodily function that occurs when the body digests food in the stomach and intestines.

During digestion, the body breaks down food into nutrients that can be absorbed into the bloodstream. However, not all food particles can be fully broken down, and some of them reach the large intestine, where they are fermented by bacteria. This fermentation process produces gases such as nitrogen, oxygen, carbon dioxide, hydrogen, and methane.

The buildup of these gases in the digestive tract can cause discomfort, bloating, and the urge to pass gas. The average person passes gas about 10-20 times a day, although this can vary widely from person to person.

While flatulence is a normal bodily function, excessive or frequent passing of gas can be a sign of an underlying digestive issue such as irritable bowel syndrome (IBS), lactose intolerance, or gastrointestinal infections. If you are experiencing persistent or severe symptoms, it is recommended to consult with a healthcare professional for further evaluation and treatment.

A peptic ulcer is a sore or erosion in the lining of your stomach and the first part of your small intestine (duodenum). The most common causes of peptic ulcers are bacterial infection and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, or naproxen.

The symptoms of a peptic ulcer include abdominal pain, often in the upper middle part of your abdomen, which can be dull, sharp, or burning and may come and go for several days or weeks. Other symptoms can include bloating, burping, heartburn, nausea, vomiting, loss of appetite, and weight loss. Severe ulcers can cause bleeding in the digestive tract, which can lead to anemia, black stools, or vomit that looks like coffee grounds.

If left untreated, peptic ulcers can result in serious complications such as perforation (a hole through the wall of the stomach or duodenum), obstruction (blockage of the digestive tract), and bleeding. Treatment for peptic ulcers typically involves medications to reduce acid production, neutralize stomach acid, and kill the bacteria causing the infection. In severe cases, surgery may be required.

The Upper Gastrointestinal (GI) Tract refers to the segment of the digestive system that includes the mouth, pharynx, esophagus, stomach, and duodenum, which is the first part of the small intestine. This region is responsible for the initial stages of digestion, such as mechanical breakdown of food by chewing and churning, and chemical breakdown through enzymes and acids. It's also where the majority of nutrient absorption occurs. Various medical conditions, including infections, inflammation, and cancers, can affect the upper GI tract.

Ranitidine is a histamine-2 (H2) blocker medication that works by reducing the amount of acid your stomach produces. It is commonly used to treat and prevent ulcers in the stomach and intestines, and to manage conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome.

Ranitidine is also used to treat gastroesophageal reflux disease (GERD) and other conditions in which acid backs up from the stomach into the esophagus, causing heartburn. Additionally, ranitidine can be used to prevent and treat upper gastrointestinal bleeding caused by stress or injury in critically ill patients.

The medication is available in both prescription and over-the-counter forms, and it comes in various forms, including tablets, capsules, and liquid solutions. As with any medication, ranitidine should be taken as directed by a healthcare professional, and its potential side effects and interactions with other medications should be carefully monitored.

A jejunostomy is a surgical procedure where an opening (stoma) is created in the lower part of the small intestine, called the jejunum. This stoma allows for the passage of nutrients and digestive enzymes from the small intestine into a tube or external pouch, bypassing the mouth, esophagus, stomach, and upper small intestine (duodenum).

Jejunostomy is typically performed to provide enteral nutrition support in patients who are unable to consume food or liquids by mouth due to various medical conditions such as dysphagia, gastroparesis, bowel obstruction, or after certain surgical procedures. The jejunostomy tube can be used for short-term or long-term nutritional support, depending on the patient's needs and underlying medical condition.

Eructation is the medical term for belching or burping. It refers to the act of expelling gas from the upper digestive tract (esophagus and stomach) through the mouth. This voluntary or involuntary action helps to relieve symptoms of bloating, discomfort, or pain caused by excessive gas build-up in the stomach. Eructation often occurs after swallowing air while eating or drinking quickly, consuming carbonated beverages, or experiencing anxiety or stress. In some cases, frequent eructations may indicate an underlying digestive disorder such as gastroesophageal reflux disease (GERD) or gastritis.

Roux-en-Y anastomosis is a type of surgical connection between two parts of the gastrointestinal tract, typically performed during gastric bypass surgery for weight loss. In this procedure, a small pouch is created from the upper stomach, and the remaining portion of the stomach is bypassed. The Roux limb, a segment of the small intestine, is then connected to both the pouch and the bypassed stomach, creating two separate channels for food and digestive juices to mix. This surgical technique helps to reduce the amount of food that can be consumed and absorbed, leading to weight loss.

An oral spray is not a medical term per se, but it refers to a type of drug delivery system where a medication is administered into the mouth by spraying it directly onto the oral mucosa (the lining of the mouth). Oral sprays are designed to deliver a specific dose of medication in a fine mist that can be easily absorbed through the mouth's mucous membranes.

Oral sprays offer several advantages, including:

1. Rapid onset of action: Since the medication is absorbed directly into the bloodstream through the oral mucosa, it bypasses the digestive system and liver metabolism, leading to a faster onset of action compared to traditional oral medications.
2. Improved patient compliance: Oral sprays are often preferred by patients who have difficulty swallowing tablets or capsules. They can also be more convenient for people on-the-go, as they do not require water or any special preparation before use.
3. Accurate dosing: Oral sprays typically come with a metered dose mechanism that ensures consistent and accurate administration of the medication.
4. Reduced side effects: As the medication is absorbed through the oral mucosa, it may result in fewer gastrointestinal side effects compared to traditional oral medications.

Examples of conditions treated with oral sprays include pain management, dry mouth, oral thrush, and nicotine dependence. It is essential to follow the instructions provided by a healthcare professional or those listed on the product label when using an oral spray to ensure safe and effective use.

Antacids are a type of medication that is used to neutralize stomach acid and provide rapid relief from symptoms such as heartburn, indigestion, and stomach discomfort. They work by chemically reacting with the stomach acid to reduce its acidity. Antacids may contain one or more active ingredients, including aluminum hydroxide, calcium carbonate, magnesium hydroxide, and sodium bicarbonate.

Antacids are available over-the-counter in various forms, such as tablets, chewable tablets, liquids, and powders. They can provide quick relief from acid reflux and related symptoms; however, they may not be effective for treating the underlying cause of these symptoms. Therefore, if you experience frequent or severe symptoms, it is recommended to consult a healthcare professional for further evaluation and treatment.

A medical definition of an ulcer is:

A lesion on the skin or mucous membrane characterized by disintegration of surface epithelium, inflammation, and is associated with the loss of substance below the normal lining. Gastric ulcers and duodenal ulcers are types of peptic ulcers that occur in the gastrointestinal tract.

Another type of ulcer is a venous ulcer, which occurs when there is reduced blood flow from vein insufficiency, usually in the lower leg. This can cause skin damage and lead to an open sore or ulcer.

There are other types of ulcers as well, including decubitus ulcers (also known as pressure sores or bedsores), which are caused by prolonged pressure on the skin.

In anatomical terms, the stomach is a muscular, J-shaped organ located in the upper left portion of the abdomen. It is part of the gastrointestinal tract and plays a crucial role in digestion. The stomach's primary functions include storing food, mixing it with digestive enzymes and hydrochloric acid to break down proteins, and slowly emptying the partially digested food into the small intestine for further absorption of nutrients.

The stomach is divided into several regions, including the cardia (the area nearest the esophagus), the fundus (the upper portion on the left side), the body (the main central part), and the pylorus (the narrowed region leading to the small intestine). The inner lining of the stomach, called the mucosa, is protected by a layer of mucus that prevents the digestive juices from damaging the stomach tissue itself.

In medical contexts, various conditions can affect the stomach, such as gastritis (inflammation of the stomach lining), peptic ulcers (sores in the stomach or duodenum), gastroesophageal reflux disease (GERD), and stomach cancer. Symptoms related to the stomach may include abdominal pain, bloating, nausea, vomiting, heartburn, and difficulty swallowing.

Hoarseness is a condition characterized by an abnormal change in the quality of voice, making it sound rough, breathy, strained, or weak. Medically, it's described as a disorder of phonation, which is the process of producing sound by vibrating the vocal cords in the larynx (voice box). Hoarseness can be caused by various factors, such as inflammation, irritation, or injury to the vocal cords, and may result in symptoms like altered voice pitch, volume, and clarity. It's essential to consult a healthcare professional if hoarseness persists for more than two weeks, especially if it's accompanied by other concerning symptoms like difficulty swallowing or breathing.

Cisapride is a medication that was used to treat gastrointestinal motility disorders, such as gastroparesis and constipation. It belongs to a class of drugs called "prokinetic agents" which work by increasing the contractions or movements of the muscles in the digestive tract, thereby helping to move food and waste through the system more efficiently.

Cisapride was first approved for use in the United States in 1993, but its use was later restricted due to concerns about serious side effects, including cardiac arrhythmias (irregular heartbeats) and interactions with other medications. In 2000, the U.S. Food and Drug Administration (FDA) requested that cisapride be withdrawn from the market due to these safety concerns.

While cisapride is no longer available for use in many countries, it may still be used in some cases under strict guidelines and monitoring conditions. It is important to note that the use of cisapride should only be initiated and monitored by a healthcare professional, and patients should inform their doctor about all other medications they are taking to avoid potential interactions.

'Perilla frutescens' is not a medical term itself, but it refers to a plant species also known as the beefsteak plant or Chinese basil. While it doesn't have a specific medical definition, some components of this plant have been studied for their potential medicinal properties. For instance, Perilla frutescens contains rosmarinic acid and luteolin, which have been researched for their anti-inflammatory, antioxidant, and neuroprotective effects. However, it is essential to note that further research is required before any definitive medical claims can be made about the plant or its components.

Metaplasia is a term used in pathology to describe the replacement of one differentiated cell type with another differentiated cell type within a tissue or organ. It is an adaptive response of epithelial cells to chronic irritation, inflammation, or injury and can be reversible if the damaging stimulus is removed. Metaplastic changes are often associated with an increased risk of cancer development in the affected area.

For example, in the case of gastroesophageal reflux disease (GERD), chronic exposure to stomach acid can lead to metaplasia of the esophageal squamous epithelium into columnar epithelium, a condition known as Barrett's esophagus. This metaplastic change is associated with an increased risk of developing esophageal adenocarcinoma.

The hypopharynx is the lower part of the pharynx, which is the muscular tube that extends from the back of the nasal cavity and mouth to the esophagus and trachea. The hypopharynx lies posterior to the larynx and is divided into three regions: the pyriform (or piriform) sinuses, the postcricoid area, and the posterior pharyngeal wall. It serves as a passageway for both food and air, and any abnormalities or diseases in this region can lead to swallowing difficulties, aspiration, and other serious medical conditions.

A gluten-free diet is a diet that excludes the consumption of gluten, a protein found in wheat, barley, and rye. This type of diet is often recommended for individuals with celiac disease, non-celiac gluten sensitivity, or wheat allergies. Adhering to a strict gluten-free diet can help manage symptoms, heal intestinal damage, and prevent further complications associated with these conditions.

The medical definition of 'Diet, Gluten-Free' includes:

1. Celiac Disease: An autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. Following a gluten-free diet is crucial for individuals with celiac disease to prevent symptoms and associated health complications.
2. Non-Celiac Gluten Sensitivity (NCGS): A condition where individuals experience adverse reactions to gluten, but do not test positive for celiac disease or wheat allergy. A gluten-free diet can help alleviate symptoms in those with NCGS.
3. Wheat Allergy: An allergic reaction to proteins found in wheat, which may include gluten. Excluding gluten from the diet can help manage symptoms in individuals with wheat allergy.
4. Dermatitis Herpetiformis (DH): A skin manifestation of celiac disease characterized by an itchy, blistering rash. A gluten-free diet is often recommended to control DH symptoms and prevent intestinal damage.
5. Gluten Ataxia: A neurological disorder associated with celiac disease where gluten ingestion can cause issues with balance, coordination, and speech. A gluten-free diet may help improve these symptoms in individuals with gluten ataxia.

It is essential to consult a healthcare professional or a registered dietitian for guidance on following a gluten-free diet to ensure proper nutrition and to avoid cross-contamination from gluten sources.

Gastric acid, also known as stomach acid, is a digestive fluid produced in the stomach. It's primarily composed of hydrochloric acid (HCl), potassium chloride (KCl), and sodium chloride (NaCl). The pH of gastric acid is typically between 1.5 and 3.5, making it a strong acid that helps to break down food by denaturing proteins and activating digestive enzymes.

The production of gastric acid is regulated by the enteric nervous system and several hormones. The primary function of gastric acid is to initiate protein digestion, activate pepsinogen into the active enzyme pepsin, and kill most ingested microorganisms. However, an excess or deficiency in gastric acid secretion can lead to various gastrointestinal disorders such as gastritis, ulcers, and gastroesophageal reflux disease (GERD).

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Sulfoxides are organic compounds characterized by the functional group consisting of a sulfur atom bonded to two oxygen atoms and a carbon atom. The general structure is R-S(=O)O-R', where R and R' represent alkyl or aryl groups. They are often formed by the oxidation of sulfides, which contain a sulfur atom bonded to two carbon atoms. Sulfoxides have a trigonal pyramidal geometry at the sulfur atom due to the presence of two electron-withdrawing oxygen atoms. They exhibit properties of both polar and nonpolar compounds, making them useful as solvents and intermediates in organic synthesis.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

Esophageal perforation is a medical condition that refers to a hole or tear in the esophagus, which is the muscular tube that connects the throat to the stomach. This condition can occur as a result of various factors such as trauma, forceful vomiting (Boerhaave's syndrome), swallowing sharp objects, or complications from medical procedures like endoscopy.

Esophageal perforation is a serious medical emergency that requires immediate attention and treatment. If left untreated, it can lead to severe complications such as mediastinitis (inflammation of the tissue surrounding the heart), sepsis, and even death. Treatment typically involves surgical repair of the perforation, antibiotics to prevent infection, and supportive care to manage any associated symptoms or complications.

Radiotherapy dosage refers to the total amount of radiation energy that is absorbed by tissues or organs, typically measured in units of Gray (Gy), during a course of radiotherapy treatment. It is the product of the dose rate (the amount of radiation delivered per unit time) and the duration of treatment. The prescribed dosage for cancer treatments can range from a few Gray to more than 70 Gy, depending on the type and location of the tumor, the patient's overall health, and other factors. The goal of radiotherapy is to deliver a sufficient dosage to destroy the cancer cells while minimizing damage to surrounding healthy tissues.

Dexlansoprazole is a proton pump inhibitor (PPI) medication that is used to treat gastroesophageal reflux disease (GERD), stomach ulcers, and other conditions caused by excessive stomach acid production. It works by blocking the action of the proton pumps in the stomach, which are responsible for producing stomach acid.

Dexlansoprazole is a single enantiomer of lansoprazole, which means that it contains only one of the two mirror-image forms of the drug. This can result in fewer side effects and improved efficacy compared to the racemic mixture (a 50/50 mix of both enantiomers) found in some other PPIs.

Dexlansoprazole is available in delayed-release capsule form, and it is typically taken once daily for the treatment of GERD or twice daily for the treatment of stomach ulcers. As with all medications, it should be used only under the supervision of a healthcare provider, who can determine the appropriate dosage and monitor for any potential side effects.

Helicobacter infections are caused by the bacterium Helicobacter pylori (H. pylori), which colonizes the stomach lining and is associated with various gastrointestinal diseases. The infection can lead to chronic active gastritis, peptic ulcers, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer.

The spiral-shaped H. pylori bacteria are able to survive in the harsh acidic environment of the stomach by producing urease, an enzyme that neutralizes gastric acid in their immediate vicinity. This allows them to adhere to and colonize the epithelial lining of the stomach, where they can cause inflammation (gastritis) and disrupt the normal functioning of the stomach.

Transmission of H. pylori typically occurs through oral-oral or fecal-oral routes, and infection is more common in developing countries and in populations with lower socioeconomic status. The diagnosis of Helicobacter infections can be confirmed through various tests, including urea breath tests, stool antigen tests, or gastric biopsy with histology and culture. Treatment usually involves a combination of antibiotics and proton pump inhibitors to eradicate the bacteria and reduce stomach acidity.

Gastrointestinal: peptic ulcer, pancreatitis, abdominal distention, and ulcerative esophagitis. Metabolic: protein catabolism ... peptic ulcer, renal insufficiency, osteoporosis, myasthenia gravis, glaucoma, and diabetes. Psychic manifestations may appear ...
Br J Surg 1947,35:218 BARRETT NR (October 1950). "Chronic peptic ulcer of the oesophagus and 'oesophagitis'". Br J Surg. 38 ( ... In this article Barrett credited Philip Rowland Allison for coining the term reflux oesophagitis in 1948, noting that was the ' ... Allison, P. R. (1 March 1948). "Peptic Ulcer of the Oesophagus". Thorax. 3 (1): 20-42. doi:10.1136/thx.3.1.20. ISSN 0040-6376. ... Allison, Philip Rowland (1946). "Peptic Ulcer of the Esophagus". Journal of Thoracic Surgery. 15 (5): 308-317. doi:10.1016/ ...
Barrett, N. R. (October 1950). "Chronic Peptic Ulcer of the Œsophagus and 'Œsophagitis'". British Journal of Surgery. 38 (150 ...
Barrett NR (October 1950). "Chronic peptic ulcer of the oesophagus and 'oesophagitis'". The British Journal of Surgery. 38 (150 ... The main cause of Barrett's esophagus is thought to be an adaptation to chronic acid exposure from reflux esophagitis. ... Allison PR (March 1948). "Peptic ulcer of the oesophagus". Thorax. 3 (1): 20-42. doi:10.1136/thx.3.1.20. PMC 1018255. PMID ... October 2008). "Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano ...
These result in heartburn and esophagitis. In combination with Helicobacter pylori infection, peptic ulcer disease is caused by ... The resulting change in pH decreases survival of the bacteria H.pylori, a major cause of peptic ulcer disease. Once the proton ... of the membrane ATPases and proton pumps in the gastrointestinal tract leads to higher secretory rates of caustic peptic acids ...
Other non-acid related causes of peptic strictures include infectious esophagitis, ingestion of chemical irritant, pill ... Biopsies are usually done to look for evidence of esophagitis even if the EGD is normal. Usually no further testing is required ... Peptic stricture is a progressive mechanical dysphagia, meaning patients will complain of initial intolerance to solids ... Progressive mechanical dysphagia is most likely due to peptic stricture or esophageal cancer. Schematically the above can be ...
Gastrointestinal diseases, such as celiac disease, Crohn's disease, peptic ulcer, eosinophilic esophagitis or non-celiac gluten ... Sores along the lining of the stomach called peptic ulcers begin to appear and the chance of developing pancreatitis increases ...
This is called esophagitis, gastritis, duodenitis, ileitis, and colitis depending on the parts affected. It can be due to ... Ulcers that affect the tract include peptic ulcers and perforated ulcer is one that has eroded completely through the layers. ...
Complications from surgical repair include Peptic ulcer disease, Gastroesophageal reflux disease, Cholecystitis, Esophagitis, ...
... for the relief of pain associated with peptic ulcer disease or esophagitis. One example of such a product is Mucaine Gel, ... indicated for "rapid and effective relief in gastritis, esophagitis, hiatus hernia, heartburn of pregnancy and peptic ulcer". ...
... erosive esophagitis, Zollinger-Ellison syndrome, and eosinophilic esophagitis. Peptic ulcers may be treated with omeprazole. ... Fitzakerley J. "2014 Treatments for Acid-Peptic Diseases". University of Minnesota Medical School Duluth. Archived from the ... A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease ... Cheng E (July 2013). "Proton pump inhibitors for eosinophilic oesophagitis". Current Opinion in Gastroenterology. 29 (4): 416- ...
Furthermore, because caffeine increases the production of stomach acid, high consumption over time may lead to peptic ulcers, ... erosive esophagitis, and gastroesophageal reflux disease. There are four caffeine-induced psychiatric disorders recognized by ...
... used to decrease gastric acid secretion in treatment of peptic ulcer disease and esophagitis (see Chapter 14), also acts as an ... Tagamet has now been largely replaced by the proton pump inhibitors for treating peptic ulcers, but is now available as an over ... It is mainly used in the treatment of heartburn and peptic ulcers. The development of longer-acting H2 receptor antagonists ... Cimetidine is used to inhibit stomach acid production and is used in the treatment of heartburn and peptic ulcers. Some ...
It is usually associated with diseases that may narrow the lumen of the esophagus, such as eosinophilic esophagitis, Schatzki ... and peptic strictures. Food boluses are common in the course of illness in patients with esophageal cancer but are more ... Kerlin P, Jones D, Remedios M, Campbell C (2007). "Prevalence of eosinophilic esophagitis in adults with food bolus obstruction ... Many alterations caused by eosinophilic esophagitis can predispose to food boluses; these include the presence of multiple ...
... gastrointestinal diseases such as esophagitis, active gastric or peptic ulcer disease, liver problems, hyperthyroidism, ...
... "peptic esophagitis" and by Bernstein and Baker who reported the symptom of heartburn following instillation of hydrochloric ... Further, only half of the patients with increased esophageal acid exposure will have esophagitis. Therefore, the diagnosis of ... sloping gradient in patients with esophagitis. Four years later, Miller used an indwelling esophageal pH electrode to ...
... esophagitis, peptic MeSH C06.405.608.698 - peptic ulcer perforation MeSH C06.405.608.849 - stomach ulcer MeSH C06.405.608.924 ... esophagitis MeSH C06.405.117.620.420 - esophagitis, peptic MeSH C06.405.205.099 - appendicitis MeSH C06.405.205.200 - cholera ... esophagitis MeSH C06.405.205.663.420 - esophagitis, peptic MeSH C06.405.205.697 - gastritis MeSH C06.405.205.697.394 - ... peptic ulcer MeSH C06.405.469.275.800.348 - duodenal ulcer MeSH C06.405.469.275.800.698 - peptic ulcer perforation MeSH C06.405 ...
... history which is typically characterized by recurrent episodes of peptic ulcer disease or by severe reflux esophagitis and/or ... They are characterized by gastric hypersecretion that results in peptic ulcers and diarrhea; this condition is known as ... One fourth of gastrinomas are related to multiple endocrine neoplasia type 1, Zollinger-Ellison syndrome, peptic ulcer disease ... esophagitis, stricture formation) Vomiting Steatorrhea Gastrin is secreted by the G cells. G cells are primarily found in the ...
These include the following: Peptic stricture Eosinophilic esophagitis Schatzki rings Achalasia Scleroderma esophagus Rarely ... "Role of endoscopic esophageal dilation in managing eosinophilic esophagitis". Medicine. 96 (14): e5877. doi:10.1097/MD. ...
... is used in form of the fumarate for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers ... and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori. Co-packaged ...
... no esophagitis 530.85 Barrett's esophagitis 531 Gastric ulcer 532 Duodenal ulcer 533 Peptic ulcer, site unspecified 534 ... and other conditions of the tongue 529.0 Glossitis 530 Diseases of esophagus 530.0 Achalasia/cardiospasm 530.1 Esophagitis, ...
It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is taken by mouth ... August 1999). "Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?". Journal of ... Prevention of NSAID-induced peptic ulcers. Given to surgery patients before operations to reduce the risk of aspiration ... Treatment for esophagitis Part of a multidrug regimen for Helicobacter pylori eradication, although omeprazole may be somewhat ...
... esophagitis, peptic ulcers, gastritis, inflammatory bowel disease, vascular ectasias, portal hypertensive gastropathy, ...
... pump inhibitor drug candidate that was undergoing clinical testing as a potential treatment for reflux oesophagitis and peptic ...
H2 antagonists can be used in the treatment of dyspepsia, peptic ulcers and gastroesophageal reflux disease. They have been ... Proton pump inhibitors, however, are the preferred treatment for erosive esophagitis since they have been shown to promote ... H2 antagonists are used by clinicians in the treatment of acid-related gastrointestinal conditions, including: Peptic ulcer ... the PPI omeprazole was found to be more effective at both healing and alleviating symptoms of ulcers and reflux oesophagitis ...
These medications are used in the treatment of many conditions, such as: Dyspepsia Peptic ulcer disease including after ... June 2010). "High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases". ... and associated laryngopharyngeal reflux causing laryngitis and chronic cough Barrett's esophagus Eosinophilic esophagitis ...
Esophagitis, esophageal varices, gastritis, cirrhosis or gastric ulcers for example, may bleed and produce coffee-ground ... When attributed to peptic inflammation, use of nonsteroidal anti-inflammatory drugs (NSAIDs) is commonly implicated. These ... "Peptic ulcer disease", Textbook of Surgery (1 ed.), Wiley, pp. 133-141, doi:10.1002/9781119468189.ch16, ISBN 978-1-119-46808-0 ... S2CID 118065272, retrieved 2023-02-17 Zerbib, Frank (2018), Bardan, Eytan; Shaker, Reza (eds.), "Erosive Esophagitis", ...
If it is caused by esophagitis, in turn caused by an underlying infection, it is commonly treated by treating the infection ( ... A benign esophageal stricture, or peptic stricture, is a narrowing or tightening of the esophagus that causes swallowing ... Chronic GERD is the most common etiology of benign esophageal strictures, referred to as peptic strictures. PDRhealth - ... It can be caused by or associated with gastroesophageal reflux disease, esophagitis, a dysfunctional lower esophageal sphincter ...
These especially include CMV and certain fungal infections, most common in immunocompromised persons Peptic ulcer disease - can ... Esophageal strictures Esophageal cancers GERD Eosinophilic esophagitis - a disease commonly associated with other atopic ... of the esophagus that are subsequently exposed to gastric acid commonly due to vomiting and/or retching Chemical esophagitis - ...
... (trade name Noltec) is a proton pump inhibitor (PPI) used in the treatment of dyspepsia, peptic ulcer disease (PUD ... Studies also showed that ilaprazole significantly prevented the development of reflux oesophagitis. Ilaprazole is developed by ... gastroesophageal reflux disease and erosive esophagitis. Ilaprazole is sold in Mexico by Chinoin Pharmaceuticals under the ...

No FAQ available that match "esophagitis peptic"

No images available that match "esophagitis peptic"